An assessment of differences in costs and health benefits of serology and NAT screening of donations for blood transfusion in different Western countries | NobleID
v1
An assessment of differences in costs and health benefits of serology and NAT screening of donations for blood transfusion in different Western countries.
M P Janssen, M van Hulst, B Custer, ABO RBDM Health Economics and Outcomes Working Group & Collaborators